Clinical Trials Browser

Phase 3 × olverembatinib × 1 year × Clear all

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase